Company Filing History:
Years Active: 2023-2025
Title: Tanja Ouimet: Innovator in Trigeminal Nerve Pain Treatment
Introduction
Tanja Ouimet is a notable inventor based in Paris, France. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of trigeminal nerve pain. Her innovative work has led to the development of a unique compound that addresses this challenging medical condition.
Latest Patents
Tanja Ouimet holds 1 patent for her invention titled "Amino acid derivatives containing a disulfanyl group in the form of an NEP and APN inhibitor for the prevention and treatment of trigeminal nerve pain." This patent focuses on a pharmaceutically acceptable salt of a compound designed to prevent or treat trigeminal nerve pain, including migraines and trigeminal neuralgia. The compound is represented by the formula (I): HN—CH(R)—CHS—S—CH—CH(R—CONH—CH(R)—COOR(I), which highlights its complex chemical structure and potential therapeutic applications.
Career Highlights
Tanja Ouimet has established herself as a key figure in her field through her innovative research and development efforts. Her work at Pharmaleads has positioned her at the forefront of pharmaceutical advancements aimed at alleviating nerve pain.
Collaborations
Tanja has collaborated with esteemed colleagues such as Hervé Poras and Marie Claude Fournie Zaluski. These partnerships have enhanced her research and contributed to the successful development of her patented invention.
Conclusion
Tanja Ouimet's contributions to the treatment of trigeminal nerve pain through her innovative patent demonstrate her commitment to advancing medical science. Her work continues to inspire and pave the way for future developments in the pharmaceutical industry.